Forest Laboratories

First Health Group Corp. Fisher Scientific Inti. Inc. Forest Laboratories Fpl Group Inc. 

Ceftaroline fosamil for injection Acute bacterial skin and skin structure infections and community-acquired pneumonia Cerexa, Forest Laboratories (Oakland, CA) 10/29/2010... 

Organon and Consultant/Speaker s Bureau Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, GlaxoSmithKline, McNeil, Otsuka, Pfizer, Inc., and Wyeth-Ay erst. ... 

Ceftaroline (PPI-0903, TAK-599) 48 (Forest Laboratories) has completed Phase III trials for the treatment of cSSSIs and is undergoing Phase III trials for the treatment of CAP.77 Ceftaroline 48 is a semi-synthetic cephalosporin derivative that was originally discovered by Takeda.78... 

Examples of marketed mucoadhesive formulations are Attach buccal tablets (triamcinolone acetonide), Susadrin sublingual tablets (nitroglycerin Forest Laboratories, NY), and Buccastem buccal tablets (prochlorperazine maleate Reckitt and Colman, England). 

Neramexane NMDA receptor antagonist Forest Laboratories... 

Forest Laboratories, Inc. Namenda (memantine hydrochloride) package insert. New York, 2004. 

The four drugs now on the market for treating AD include Aricept by Eisai and Pfizer, Exelon by Novartis, Razadyne by Johnson Johnson, and Namenda by Forest Laboratories. These drugs inhibit the enzyme cholinesterase that is responsible for the breakdown of acetylcholine in the brain. These drugs seem to postpone the worsening of Alzheimer s symptoms for 6-12 months in about half of the people who take them. 

Forest Laboratories 2006 Annual Report, p. 13. Available at http //library.corporate-ir.net/library/83/831/ 83198/items/203929/Stockholders-Letter AR06.r3.pdf... 

See Forest Laboratories 2006 Annual Report. Forest was in the middle of successfully fending off a challenge to one of its patents when this was written. 

Carisoma (Carisoprodol). Forest Laboratories UK Ltd. UK Summary of product characteristics, July 2006. 

Syscor MR (Nisoldipine). Forest Laboratories UK UK Summary of prt uct characteris-... 

Tularaemia results from systemic infection with the gram-negative bacteria Francisella tularensis. Wild rodents (in particular, hares) and other small-animal populations are the main reservoir of infection. In humans, most cases are sporadic, related to tick bites (Dermacentor) or direct contact with infected animals. Hunters are at greatest risk, but the disease also affects butchers, farmers, foresters, laboratory workers and veterinarians (Evans et al. 1985). The incubation period varies from 1 day to 10 days. The clinical manifestation is usually an ulcerated nodule at the point of inoculation, associated with enlargement and, later, breakdown of lymph nodes. Systemic symptoms and toxaemia may be severe. Minocycline is considered to be efficacious in most cases (100 mg twice per day for 4 weeks). 

Manufacturer Forest Pharmaceuticals, a subsidiary of Forest Laboratories, Professional Affairs Department, 13600 Shoreline Drive, St Louis, MO 63045... 

Manufacturer Forest Laboratories, Inc., 909 Third Avenue, New York, NY 10022 Merz Pharmaceuticals, Frankfurt, Germany Chemical Structure see Figure 129.1... 

Goldman-Sachs Global Healthcare. Goldman Sachs Global Healthcare Conference. Forest Laboratories Inc., Company Presentation, 2006. 

Another example of chiral switching is that of the selective serotonin leuptake inhibitor (SSRI) antidepressant Celexa, which was introduced to the market in 1998 by Forest Laboratories. Celexa is a racemic mixture of (i )-citalopram oxalate and (5)-dtalopram oxalate. While only... 

Paroxetine has two chiral carbons and is administered as a single stereoisomer. Citalopram is one chiral carbon and is administered as a racemic mixture in Celexa and as the pure S enantiomer in escitalopram oxalate (Lexapro , Forest Laboratories). 

Nhut Diep, Gian-Luca Araldi, and Alexander Bischoff, Medicinal Chemistry and Process Development, Forest laboratories institute, 45 Adams Ave, Hauppauge, NY 11788... 

Pickling is carried out in accordance with one or other of several European and American specifications [7,22,23]. It should be noted that the DEF STAN documentation replaces the original DTD 915B (ii) specification of 1956 that was used throughout Europe until recently. The BAC (Boeing) specification and the original Forest Laboratory s Process (FLP etch), used in the United States of America, are similar. 

Another example of chiral switching is that of the selective serotonin reuptake inhibitor (SSRI) antidepressant Celexa, which was introduced to the market in 1998 by Forest Laboratories. Celexa is a racemic mixture of (i )-citalopram oxalate and (5)-citalopram oxalate. While orrly the (S) enantiomer has therapeutic antidepressant properties, both enantiomers contribute to the side effects of the drug and therefore limit effectiveness and patient tolerance. In 2002, the FDA approved Lexapro, a new antidepressant derived from Celexa but from which the therapeutically ineffective (R) enantiomer has been removed. The benefits of isolating the active isomer include smaller required dosages, reduced side effects, and a faster and better patient response to the drag. 

---